Lawrence Blatt
Chief Executive Officer at ALIGOS THERAPEUTICS, INC.
Net worth: 879 011 $ as of 2024-04-29
Lawrence Blatt active positions
Companies | Position | Start | End |
---|---|---|---|
ALIGOS THERAPEUTICS, INC. | Chairman | - | - |
Chief Executive Officer | 2018-02-04 | - | |
Founder | 2018-02-04 | - | |
Director/Board Member | 2018-02-04 | - | |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Director/Board Member | - | - |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Director/Board Member | - | - |
Career history of Lawrence Blatt
Former positions of Lawrence Blatt
Companies | Position | Start | End |
---|---|---|---|
JOHNSON & JOHNSON | Corporate Officer/Principal | 2014-10-31 | 2018-01-31 |
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | Director/Board Member | 2008-12-31 | 2014-10-31 |
Chief Executive Officer | 2008-12-31 | 2014-10-31 | |
Founder | 2007-12-31 | 2014-10-31 | |
President | 2008-12-31 | 2014-10-31 | |
INTERMUNE INC | Chief Tech/Sci/R&D Officer | 2001-12-31 | 2007-12-31 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 1997-12-31 | 2002-04-30 |
National Genetics Institute, Inc.
National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Part of Laboratory Corp. of America Holdings, National Genetics Institute, Inc. provides hepatitis C testing and other laboratory services. The company is based in Los Angeles, CA. The company was founded by Andrew J. Conrad, Michael A. Aicher. National Genetics Institute was acquired by Laboratory Corp. of America Holdings on August 01, 2000. | Corporate Officer/Principal | 1996-07-31 | 1997-12-31 |
Meissa Vaccines, Inc.
Meissa Vaccines, Inc. BiotechnologyHealth Technology Meissa Vaccines, Inc. operates as a pharmaceutical development company. It focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus. The company was founded by Marty Moore and Roderick Tang in 2014 and is headquartered in South San Francisco, CA. | Chairman | 2018-03-12 | - |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - |
Training of Lawrence Blatt
California State University-Northridge | Masters Business Admin |
Indiana University | Undergraduate Degree |
University of La Verne | Doctorate Degree |
Statistics
International
United States | 13 |
United Kingdom | 2 |
Operational
Director/Board Member | 4 |
Chairman | 3 |
Founder | 3 |
Sectoral
Health Technology | 8 |
Consumer Services | 4 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
JOHNSON & JOHNSON | Health Technology |
ALIGOS THERAPEUTICS, INC. | Health Technology |
Private companies | 8 |
---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
National Genetics Institute, Inc.
National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Part of Laboratory Corp. of America Holdings, National Genetics Institute, Inc. provides hepatitis C testing and other laboratory services. The company is based in Los Angeles, CA. The company was founded by Andrew J. Conrad, Michael A. Aicher. National Genetics Institute was acquired by Laboratory Corp. of America Holdings on August 01, 2000. | Process Industries |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Commercial Services |
Alveo Technologies, Inc.
Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Alveo Technologies, Inc. operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices. The company was founded by Ron Chiarello, Michael A. Aicher, Lawrence M. Blatt and Sumita Pennathur in 2014 and is headquartered in Alameda, CA. | Health Technology |
Meissa Vaccines, Inc.
Meissa Vaccines, Inc. BiotechnologyHealth Technology Meissa Vaccines, Inc. operates as a pharmaceutical development company. It focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus. The company was founded by Marty Moore and Roderick Tang in 2014 and is headquartered in South San Francisco, CA. | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | Health Technology |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Lawrence Blatt
- Experience